Does Group Health Cooperative (GHC) Cover Viagra?

GHC Is Now Kaiser Permanente Washington

Group Health Cooperative, a Seattle-based nonprofit health plan founded in 1947, completed its merger with Kaiser Permanente on February 1, 2017. If your insurance card still references GHC, your coverage is now administered by Kaiser Permanente Washington. All formulary decisions, prior authorization protocols, and pharmacy benefits fall under Kaiser Permanente's national pharmacy governance structure, with regional adjustments for Washington state members.

Why the Name Change Matters for Prescriptions

Pharmacy claims now route through Kaiser Permanente's integrated system. Members who previously filled prescriptions at GHC pharmacies can still use Kaiser Permanente Washington pharmacy locations, but the drug formulary has been updated to reflect Kaiser Permanente's national preferred drug list. Sildenafil's placement on that list determines your copay.

Checking Your Current Plan

The fastest way to confirm your specific coverage is to log in at kp.org and search the formulary tool for "sildenafil." You can also call the Member Services number on the back of your card. Plan documents from open enrollment specify which tier ED medications occupy, and whether quantity limits or step therapy apply.

How Sildenafil and Viagra Appear on the Formulary

Kaiser Permanente Washington maintains a multi-tier formulary. Generic sildenafil typically occupies Tier 2 (preferred generic or preferred brand), while brand-name Viagra, when listed at all, sits on Tier 3 or Tier 4 (non-preferred brand or specialty). The practical difference is significant: a Tier 2 generic copay might be $10 to $30 per fill, while a non-preferred brand copay could exceed $75 to $100 for the same medication.

Generic vs. Brand-Name Pricing

Pfizer's U.S. Patent on Viagra expired in 2020, and multiple manufacturers now produce FDA-approved generic sildenafil citrate tablets. The FDA's Orange Book confirms therapeutic equivalence ratings (AB-rated) for these generics, meaning they deliver the same clinical effect. A 2018 analysis published in JAMA Internal Medicine found that generic entry reduced sildenafil prices by over 90% within two years of patent expiration [1]. Most insurers, Kaiser Permanente Washington included, strongly favor generics on lower copay tiers.

Quantity Limits and Refill Rules

Most commercial and Medicare plans impose quantity limits on PDE5 inhibitors. A common cap is 6 tablets per 30 days, though some plans allow up to 12. These limits are based on labeled dosing: the FDA-approved prescribing information for sildenafil recommends one dose per day as needed, approximately one hour before sexual activity [2]. If your provider believes a higher quantity is medically necessary, a prior authorization or quantity limit exception can be submitted.

Clinical Criteria for Coverage

Insurance coverage for erectile dysfunction medications is not automatic. Kaiser Permanente Washington, like most large health plans, requires a confirmed diagnosis.

What Qualifies as Erectile Dysfunction

The American Urological Association (AUA) defines erectile dysfunction as the persistent inability to attain or maintain an erection sufficient for satisfactory sexual performance [3]. A 2019 meta-analysis in The Journal of Sexual Medicine estimated that ED affects approximately 30 million men in the United States, with prevalence increasing sharply after age 40 [4]. The Massachusetts Male Aging Study, one of the largest epidemiological investigations of ED, reported that 52% of men between ages 40 and 70 experience some degree of erectile dysfunction [5].

Diagnostic Requirements

Your provider will typically document the following before prescribing sildenafil: symptom duration (generally at least three months), a physical examination, relevant lab work (testosterone level, fasting glucose, lipid panel), and a review of medications that may contribute to ED. The Endocrine Society's 2018 clinical practice guideline recommends measuring serum testosterone in all men presenting with ED, as hypogonadism is a treatable underlying cause in 10% to 20% of cases [6].

Step Therapy Considerations

Some Kaiser Permanente Washington plans use step therapy, requiring patients to try generic sildenafil before the plan will approve brand-name Viagra or other PDE5 inhibitors like tadalafil (Cialis) or avanafil (Stendra). This approach aligns with guidance from the American College of Physicians, which states: "PDE5 inhibitors are recommended as first-line pharmacotherapy for erectile dysfunction; choice among agents should be based on patient preference, cost, and ease of use" [7].

What Prior Authorization Involves

Prior authorization (PA) is a utilization management tool where your insurer reviews a prescription before approving coverage. Not every Kaiser Permanente Washington plan requires PA for sildenafil, but certain circumstances trigger it.

Common PA Triggers

PA is more likely if you request brand-name Viagra instead of generic sildenafil, if you need quantities exceeding the standard limit, if you are under age 18, or if you have certain cardiovascular contraindications that require clinical review. The process typically takes 24 to 72 hours for standard requests. Urgent requests can be expedited to within 24 hours.

How to Appeal a Denial

If your PA is denied, you have the right to appeal. Kaiser Permanente Washington follows Washington state insurance appeal regulations, which require a first-level internal review within 30 days and an expedited review within 72 hours for urgent cases. The Washington State Office of the Insurance Commissioner provides a consumer guide to appeals and grievances that outlines your rights under state law.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a lead author on the AUA's erectile dysfunction guideline, has noted: "Access to PDE5 inhibitors should not be restricted by overly burdensome administrative requirements when a patient meets standard clinical criteria for erectile dysfunction" [3].

Cost Without Insurance or on a High-Deductible Plan

Even with Kaiser Permanente Washington coverage, members on high-deductible health plans (HDHPs) may pay full price until meeting their deductible. Generic sildenafil is one of the most affordable ED medications available.

Retail Cash Prices

According to 2025 pharmacy pricing data, generic sildenafil 20 mg tablets (often prescribed in multiples for ED dosing at 40 to 100 mg) range from $0.30 to $2.00 per tablet at large retail pharmacies. The 50 mg and 100 mg tablet strengths marketed specifically for ED typically cost $1 to $6 per tablet. Brand-name Viagra, by contrast, can exceed $70 per tablet without insurance.

Manufacturer and Pharmacy Discount Programs

Several manufacturer discount cards and pharmacy savings programs can reduce out-of-pocket costs. GoodRx, RxSaver, and similar aggregators show real-time pricing at pharmacies near you. Kaiser Permanente Washington members who fill prescriptions at Kaiser Permanente mail-order pharmacy may receive a 90-day supply at a lower per-unit cost compared to 30-day retail fills.

Alternatives Covered by Kaiser Permanente Washington

Sildenafil is not the only PDE5 inhibitor. If it does not work well for you or causes side effects (headache, flushing, nasal congestion, visual disturbances), other options may be on formulary.

Other PDE5 Inhibitors

Tadalafil (generic Cialis) is widely covered and offers a longer duration of action (up to 36 hours vs. 4 to 6 hours for sildenafil). A 2019 Cochrane systematic review comparing PDE5 inhibitors for ED found that all four FDA-approved agents (sildenafil, tadalafil, vardenafil, avanafil) produced statistically significant improvements in erectile function scores vs. Placebo, with no consistent superiority of one agent over another [8]. Tadalafil is also FDA-approved for daily use at 2.5 mg or 5 mg, which some men prefer for spontaneity.

Non-PDE5 Options

For men who cannot take PDE5 inhibitors (those on nitrates, for example, face a contraindication flagged by the FDA due to the risk of severe hypotension [2]), alternatives include alprostadil injections (Caverject), intraurethral alprostadil (MUSE), vacuum erection devices, and penile prosthesis surgery. Coverage for these alternatives varies by plan. A referral to urology is typically required.

Testosterone Replacement Therapy

When ED is caused by documented hypogonadism (total testosterone below 300 ng/dL on two morning samples), testosterone replacement therapy (TRT) may restore erectile function and can be combined with a PDE5 inhibitor. The Endocrine Society guideline recommends TRT for symptomatic men with unequivocally low testosterone, noting that testosterone therapy alone improves erectile function in approximately 50% of hypogonadal men with ED [6]. The TRAVERSE trial (N=5,204), published in The New England Journal of Medicine in 2023, confirmed that testosterone replacement in men with hypogonadism and cardiovascular risk did not increase the incidence of major adverse cardiac events compared to placebo [9].

Medicare and Medicaid Considerations

Coverage rules differ for government-sponsored plans.

Medicare Part D

Medicare Part D plans have historically excluded coverage of ED medications under the Social Security Act. This means Medicare beneficiaries enrolled in Kaiser Permanente Washington's Medicare Advantage plans may not have sildenafil covered for erectile dysfunction. Sildenafil is covered under Part D when prescribed for pulmonary arterial hypertension (marketed as Revatio at the 20 mg strength). Members should verify their specific plan's formulary, as some Medicare Advantage plans offer supplemental drug coverage that may include ED medications.

Washington Apple Health (Medicaid)

Washington's Medicaid program (Apple Health) has variable coverage for ED medications. Fee-for-service Medicaid in Washington has not traditionally included PDE5 inhibitors for ED on its preferred drug list, though managed care organizations contracted with Apple Health may offer coverage through supplemental benefits. Eligibility and coverage can change annually; the Washington Health Care Authority publishes updated preferred drug lists at hca.wa.gov.

Safety Screening Before Starting Sildenafil

A prescription for sildenafil is not just a formulary question. Your provider must confirm it is safe for you.

Cardiovascular Risk Assessment

The Princeton III Consensus Recommendations, published in The Journal of Sexual Medicine, stratified cardiovascular risk in men seeking ED treatment into low, intermediate, and high categories [10]. Men at low cardiac risk (able to climb two flights of stairs without symptoms) can start PDE5 inhibitors without further cardiac workup. Men at high risk (unstable angina, recent MI within two weeks, uncontrolled hypertension above 170/100 mmHg) should have their cardiac condition stabilized before starting therapy.

Dr. Ajay Nehra, former chair of the AUA's erectile dysfunction guideline panel, stated: "Erectile dysfunction is often a sentinel marker for underlying cardiovascular disease, and every man presenting with ED deserves a cardiovascular risk assessment" [3].

Drug Interactions to Disclose

Sildenafil must never be combined with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or riociguat. Concomitant use of alpha-blockers requires dose adjustment. CYP3A4 inhibitors such as ketoconazole, ritonavir, and erythromycin can increase sildenafil plasma levels, requiring a lower starting dose. The FDA prescribing information recommends a 25 mg starting dose when sildenafil is co-administered with strong CYP3A4 inhibitors [2].

How to Get Started With Coverage

If you are a Kaiser Permanente Washington member (formerly GHC) and want to use your benefits for sildenafil, follow these steps. Schedule an appointment with your primary care provider or a urologist within the Kaiser Permanente network. Discuss your symptoms, undergo the necessary evaluation, and obtain a prescription. Ask your provider to prescribe generic sildenafil citrate by name to ensure formulary-preferred status. Fill the prescription at a Kaiser Permanente pharmacy or a network retail pharmacy. If prior authorization is needed, your provider's office will submit the request electronically. The standard turnaround is 24 to 72 hours.